Neutralization of B.1.1.28 P2 variant with sera of natural SARS-CoV-2 infection and recipients of inactivated COVID-19 vaccine Covaxin

Our study has shown 1.09 and 1.92 fold reductions in the neutralizing titer with sera of individuals with natural infection and Covaxin vaccine recipients against B.1.1.28.2 variant.

Enregistré dans:
Détails bibliographiques
Publié dans:J Travel Med
Auteurs principaux: Sapkal, Gajanan, Yadav, Pragya D, Ella, Raches, Abraham, Priya, Patil, Deepak Y, Gupta, Nivedita, Panda, Samiran, Mohan, V Krishna, Bhargava, Balram
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2021
Sujets:
Rapid Communication
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8194512/
https://ncbi.nlm.nih.gov/pubmed/34002240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jtm/taab077
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires